
SpaceX is reportedly targeting a valuation above $2 trillion and a roughly $75 billion IPO raise, which would make it the largest listing in history, but the article argues the setup is unattractive for investors. At an implied 108x sales on $18.5 billion of revenue and with $5 billion in losses last year, the company would debut at a far richer multiple than prior mega-IPOs such as Meta, Alibaba, SoftBank, Saudi Aramco, and GM. The piece concludes that most mega-IPOs have underperformed and advises against buying SpaceX at the offering price.
The immediate market signal is not “SpaceX goes public,” but “private-market price discovery is about to compress every frontier-technology multiple.” A $2T anchor would re-rate investor expectations for capital intensity, runway, and scarcity premium across adjacent names, but it also creates a high bar for follow-on growth in any company selling a long-duration narrative. The first-order beneficiaries are likely pre-IPO suppliers, launch-adjacent contractors, and late-stage private rounds that can now reference a much richer comp set; the losers are any public space/defense or satellite adjacency names already trading on scarcity rather than cash flow. The bigger second-order effect is that a marquee IPO at this valuation can pull capital out of public growth into private-market lockups just as performance dispersion is widening. If the deal is heavily oversubscribed, it may temporarily siphon demand from META/NVDA/INTC-style “AI infrastructure” exposures because allocators will want venture-like upside with a public wrapper. But if the stock breaks post-listing, it becomes a negative signal for all long-duration assets: the risk is not just valuation mean reversion, it is a drawdown in the willingness to underwrite profitability far into the future. The consensus seems to be focusing on the moat and ignoring the dilution/secondary overhang that a $75B raise implies. For existing holders, a huge capital raise at an extreme multiple is often a signal that management is monetizing scarcity near cycle peak rather than compounding through operations; for new buyers, the embedded expectation is so high that even strong execution can underwhelm for multiple quarters. The key catalyst window is the first 1-3 months after pricing, when lockup dynamics, insider selling, and underwriter support usually matter more than fundamentals. Contrarianly, the best trade may be to fade the IPO enthusiasm indirectly rather than short the asset outright. If this list gets hot, names that already trade on “next-gen monopoly” narratives can see sympathy inflows, but they also become the easiest source of funds if the IPO stalls. That makes the setup more interesting in pairs than in outright direction.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly negative
Sentiment Score
-0.35
Ticker Sentiment